Back to Journals » Journal of Pain Research » Volume 4

Evaluation of pain associated with facial injections using CoolSkin® in rhytidectomy

Authors Taghizadeh F, Ellison T, Traylor-Knowles M

Published 29 September 2011 Volume 2011:4 Pages 309—313


Review by Single anonymous peer review

Peer reviewer comments 2

Farhan Taghizadeh, Timothy Ellison, Mimi Traylor-Knowles
Lifestyle Lift Innovation Center, Albuquerque, NM, USA

Purpose: To evaluate the use of the CoolSkin® (Elbio, Seoul, Korea) skin-cooling device to reduce injection pain during rhytidectomy.
Method: Nineteen patients underwent rhytidectomy using the CoolSkin at -4°C on the first side lateral injection. The second side was then started without the cooling. Patients were offered cooling if they desired it on the second side. Surveys were administered 24 hours after the procedure, comparing pain (scale 0–5) and investigating treatment preferences. Patient healing was tracked for 6 weeks.
Results: Mean pain score for the untreated side was 4.63 versus 2.37 for the CoolSkin-treated side (P < 0.001). All patients asked for the second side to be cooled, and 89% were in favor of the chilling procedure when surveyed 24 hours afterwards. Sixty eight percent of patients stated that this device reduced fear of future injections. No flap loss or healing sequelae were noted from device use.
Conclusion: The CoolSkin device is an effective tool to reduce injection pain laterally during rhytidectomy.

Keywords: pain, cooling, rhytidectomy, CoolSkin®, facial injections, face lift

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.